Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Ureteral Neoplasms × erdafitinib × Clear all

Sponsor

Conditions

Urothelial Cancer 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Rhabdoid Tumor 1 Non-Muscle Invasive Bladder Neoplasms 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Multiple Myeloma 1 Medulloblastoma 1 Malignant Solid Neoplasm 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Histiocytosis, Langerhans-Cell 1 Hepatoblastoma 1 Glioma 1 Familial ependymoma 1 Ependymoma 1 Central Nervous System Neoplasms 1 Carcinoma, Transitional Cell 1 Breast Neoplasms 1 Advanced Solid Tumor 1

Interventions

Gemcitabine 5 Cisplatin 4 enfortumab vedotin 2 Ramucirumab 2 Platinum 2 Docetaxel 2 1,2-diaminocyclohexaneplatinum II citrate 2 vinflunine 1 rucaparib 1 pembrolizumab 1 eribulin 1 enzalutamide 1 dehydroftorafur 1 carotuximab 1 avelumab 1 atezolizumab 1 Standard of Care 1 Specimen Handling 1 Radiotherapy 1 Radiation 1 Paclitaxel 1 N-(3-aminopropyl)-N-(1-(5-benzyl-3-methyl-4-oxo-(1,2)thiazolo(5,4-d)pyrimidin-6-yl)-2-methylpropyl)-4-methylbenzamide 1 Mitozytrex 1 Mitomycin 1 Magnetic Resonance Spectroscopy 1 Interleukin-7 1 Immunoglobulin G 1 Icrucumab 1 IMC-18F1 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡